The New Direct Oral Anticoagulants in Special Indications: Rationale and Preliminary Data in Cancer, Mechanical Heart Valves, Anti-phospholipid Syndrome, and Heparin-Induced Thrombocytopenia and BeyondALBERIO, Lorenzo.Seminars in hematology. 2014, Vol 51, Num 2, pp 152-156, issn 0037-1963, 5 p.Article

Titre of anti-heparin/PF4-antibodies and extent of in vivo activation of the coagulation and fibrinolytic systemsCHILVER-STAINER, Lara; LÄMMLE, Bernhard; ALBERIO, Lorenzo et al.Thrombosis and haemostasis. 2004, Vol 91, Num 2, pp 276-282, issn 0340-6245, 7 p.Article

Monitoring Thrombin Generation by Electrochemistry : Development of an Amperometric Biosensor Screening Test for Plasma and Whole BloodTHUERLEMANN, Charles; HAEBERLI, André; ALBERIO, Lorenzo et al.Clinical chemistry (Baltimore, Md.). 2009, Vol 55, Num 3, pp 505-512, issn 0009-9147, 8 p.Article

Rapid exclusion or confirmation of heparin-induced thrombocytopenia: a single-center experience with 1,291 patientsNELLEN, Vanessa; SULZER, Irmela; BARIZZI, Gabriela et al.Haematologica (Roma). 2012, Vol 97, Num 1, pp 89-97, issn 0390-6078, 9 p.Article

Rapid determination of anti-heparin/platelet factor 4 antibody titers in the diagnosis of heparin-induced thrombocytopeniaALBERIO, Lorenzo; KIMMERLE, Sabine; BAUMANN, Annalies et al.The American journal of medicine. 2003, Vol 114, Num 7, pp 528-536, issn 0002-9343, 9 p.Article

ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patientsVESELY, Sara K; GEORGE, James N; LÄMMLE, Bernhard et al.Blood. 2003, Vol 102, Num 1, pp 60-68, issn 0006-4971, 9 p.Article

Use of the pentasaccharide fondaparinux as an anticoagulant during haemodialysisKALICKI, Robert M; AREGGER, Fabienne; ALBERIO, Lorenzo et al.Thrombosis and haemostasis. 2007, Vol 98, Num 6, pp 1200-1207, issn 0340-6245, 8 p.Article

Splenectomy in relapsing and plasma-refractory acquired thrombotic thrombocytopenic purpuraKREMER HOVINGA, Johanna A; STUDT, Jan-Dirk; DEMARMELS BIASIUTTI, Franziska et al.Haematologica (Roma). 2004, Vol 89, Num 3, pp 320-324, issn 0390-6078, 5 p.Article

Massive muscle haematoma three months after starting vitamin K antagonist therapy for deep-vein thrombosis in an antithrombin deficient patient: Another case of factor IX propeptide mutationJAHNS, Maximilian; FRIESS, Dorothea; DEMARMELS BIASIUTTI, Franziska et al.Thrombosis and haemostasis. 2011, Vol 106, Num 2, pp 381-382, issn 0340-6245, 2 p.Article

Plasma therapy in thrombotic thrombocytopenic purpura: Review of the literature and the bern experience in a subgroup of patients with severe acquired ADAMTS-13 deficiencyFONTANA, Stefano; HOVINGA, Johanna A; STUDT, Jan-Dirk et al.Seminars in hematology. 2004, Vol 41, Num 1, pp 48-59, issn 0037-1963, 12 p.Article

Von willebrand factor-cleaving protease (ADAMTS-13) activity determination in the diagnosis of thrombotic microangiopathies: The Swiss experienceHOVINGA, Johanna A; STUDT, Jan-Dirk; ALBERIO, Lorenzo et al.Seminars in hematology. 2004, Vol 41, Num 1, pp 75-82, issn 0037-1963, 8 p.Article

Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surfaceDALE, George L; FRIESE, Paul; BATAR, Peter et al.Nature (London). 2002, Vol 415, Num 6868, pp 175-179, issn 0028-0836Article

Stability of low molecular weight heparin anti-factor Xa activity in citrated whole blood and plasmaBIRRI, Nicole; BAUMGARTNER, Daniela; CONTE, Tiziana et al.British journal of haematology. 2011, Vol 155, Num 5, pp 629-631, issn 0007-1048, 3 p.Article